CTRI/2023/09/057399招募中3 期
A randomized controlled trial on Safety and Immunogenicity of purified verocell rabies vaccine as pre-exposure prophylaxis via Intradermal two visits (2-0-2-0-0) verses three visits (1-0-1-0-1) regimen on healthy volunteers - NI
Dr N R Ramesh Masthi0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Healthy subjects willing to volunteer and sign written informed consent for the study.
- •Subjects should be available for the follow-up period.
排除标准
- •?Received Anti rabies vaccine or RIG or RMAb anytime in the past.
- •?Participation in any other clinical trial in the past three months.
- •?Severely immunocompromised subjects, pregnant and lactating women.
- •Subjects with known history of allergy.
研究者
相似试验
招募中
1 期
evaluate the safety and immunomodulatory efficacy of Byolic CC supplementImmunomodulatory effect on healthy volunteers.IRCT20240304061158N4Behpad Teb Iranian90
进行中（未招募）
不适用
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and ChildreJapanese EncephalitisEUCTR2015-005193-38-Outside-EU/EEASanofi Pasteur SA300
已完成
3 期
A prospective randomized controlled trial of immunoglobulin plus prednisolone for Kawasaki disease patients with high risk for coronary abnormalitiesKawasaki diseaseJPRN-UMIN000009524agoya University Graduate School of Medicine, Department of Pediatrics240
已完成
不适用
A randomized controlled trial of immune-enhancing enteral feeding on immunologic and nutritional status in tube-fed patientsmalnutritionJPRN-UMIN000001326Morinaga Milk Industry Co., Ltd.126
招募中
3 期
Clinical Trial of quadrivalent Papilloguard4 vaccine (Human Papillomavirus Types 6, 11, 16, 18) manufactured by Nivad Pharmed Salamat in comparison with GardasilGenital wart prevention.Anogenital (venereal) wartsA63.0IRCT20240120060741N1ivad Pharmed Salamat670